PridCor Therapeutics, LLC is a privately held, clinical-stage biopharmaceutical company headquartered in Tuscaloosa, Alabama, focused on developing novel antiviral therapies and securing global antiviral portfolios.
Subscribe to see PridCor Therapeutics, LLC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
PridCor Therapeutics, LLC is a company headquartered in United States. Its most recent funding round raised $6M in May 2026. Xcout tracks 6 named people at PridCor Therapeutics, LLC, including William L. Pridgen (Chief Executive Officer).
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | $6M | — | |
| SEC Form D filing | $1M | — | |
| — | $40,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of PridCor Therapeutics, LLC's closest competitors — see the full list of competitors and alternatives →
Pardes Biosciences, Inc. is a clinical-stage biopharmaceutical company based in Carlsbad, California. The company focuses on the development of novel oral antiviral treatments for viral diseases.
Khaya Biosciences, Inc., also known as Khaya Bio, Inc., is a bioscience company with its principal office address located in Dothan, Alabama.
Red Queen Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on antiviral therapeutics, with its headquarters located in Cambridge, Massachusetts.
PrEP Biopharm Ltd is a biopharmaceutical company located in northern Italy that develops antiviral drugs and therapeutic pipelines.
Iaso Therapeutics, Inc. is a biopharmaceutical and biotechnology company headquartered in East Lansing, Michigan, dedicated to redefining infectious disease prevention and drug research.
Island Pharmaceuticals Ltd is an Australian antiviral drug development company based in Melbourne, Australia, focused on addressing infectious diseases.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.